Unione Europea - italiano - EMA (European Medicines Agency)

mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Unione Europea - italiano - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Unione Europea - italiano - EMA (European Medicines Agency)

teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

galderma sa - methylis aminolaevulinas - crema - methylis aminolaevulinas 160 mg ut methylis aminolaevulinatis hydrochloridum, glyceroli monostearas emulsifcans, alcohol cetylicus et stearylicus 40 mg, macrogoli stearas, e 218 2 mg, propylis parahydroxybenzoas 1 mg, dinatrii edetas, glycerolum, vaselinum album, cholesterolum, isopropylis myristas, arachidis oleum 30 mg, amygdalae oleum, alcohol oleicus, aqua, ad unguentum pro 1 g. - cheratosi attinica e superficiale vescicali basalioma maligno - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, zucchero sfere corrisp. sintetico 10.9 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 3.87 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, e 172 (giallo), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, zucchero sfere corrisp. sintetico 16.36 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 5.78 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 172 (giallo), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, zucchero sfere corrisp. la biomassa 21.8 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 7.71 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 54 mg, zucchero sfere corrisp. la biomassa 32.7 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 11.57 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, e 172 (rosso), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.